• Children with a history of CVC-associated thrombosis are at increased risk for recurrent VTE.

  • With subsequent CVC placement, secondary prophylaxis with full-dose anticoagulation was associated with a 65% reduction in thromboembolism.

Central venous catheters (CVC) are the most significant risk factor for pediatric venous thromboembolism (VTE). After an index CVC-associated VTE (CVC-VTE), the role of secondary prophylaxis for subsequent CVC placement is uncertain. Aims of this single-center retrospective study were to evaluate the efficacy of secondary prophylaxis for patients with a prior CVC-VTE and identify risk factors associated with recurrent VTE in patients less than 19 years with an index CVC-VTE between 2003 and 2013. Data collection included clinical and demographic factors, subsequent CVC placement, secondary prophylaxis strategy, recurrent VTE, and bleeding. Risk factors for recurrence and effectiveness of secondary prophylaxis were evaluated using survival and binomial models. Among 373 patients with an index CVC-VTE, 239 (64.1%) had subsequent CVC placement; 17.4% (65/373) of patients had recurrent VTE, of which 90.8% (59/65) were CVC-associated. On multivariable survival analysis, each additional CVC (hazards ratio [HR] 12.00; 95% confidence interval [CI] 2.78-51.91), congenital heart disease (HR 3.70; 95% CI 1.97-6.95), and total parenteral nutrition dependence (HR 4.02; 95% CI 2.23-7.28) were associated with an increased hazard of recurrence. Full dose anticoagulation for secondary prophylaxis was associated with decreased odds of recurrent CVC-VTE (odds ratio [OR] 0.35; 95% CI 0.19-0.65) but not prophylactic dosing (OR 0.61; 95% CI 0.28-1.30). Only 1.3% of CVCs experienced major bleeding with prophylactic or full-dose anticoagulation. In summary, children with CVC-VTE are at increased risk for recurrent VTE. Secondary prophylaxis with full-dose anticoagulation was associated with a 65% reduction in odds of thrombotic events.

1.
Kuhle
S
,
Massicotte
P
,
Chan
A
, et al
.
Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service
.
Thromb Haemost.
2017
;
92
(
10
):
722
-
728
.
2.
Raffini
L
,
Huang
YS
,
Witmer
C
,
Feudtner
C
.
Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007
.
Pediatrics.
2009
;
124
(
4
):
1001
-
1008
.
3.
Andrew
M
,
David
M
,
Adams
M
, et al
.
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE
.
Blood.
1994
;
83
(
5
):
1251
-
1257
.
4.
Mahajerin
A
,
Croteau
SE
.
Epidemiology and risk assessment of pediatric venous thromboembolism
.
Front Pediatr.
2017
;
5
(
5
):
68
.
5.
Jaffray
J
,
Mahajerin
A
,
Young
G
, et al
.
A multi-institutional registry of pediatric hospital-acquired thrombosis cases: The Children’s Hospital-Acquired Thrombosis (CHAT) project
.
Thromb Res.
2018
;
161
:
67
-
72
.
6.
Mahajerin
A
,
Branchford
BR
,
Amankwah
EK
, et al
.
Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk-assessment models
.
Haematologica.
2015
;
100
(
8
):
1045
-
1050
.
7.
Monagle
P
,
Chan
AKC
,
Goldenberg
NA
, et al
.
Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
.
Chest.
2012
;
141
(
2 Suppl
):
e737S
-
e801S
.
8.
Monagle
P
,
Cuello
CA
,
Augustine
C
, et al
.
American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism
.
Blood Adv.
2018
;
2
(
22
):
3292
-
3316
.
9.
Witmer
CM
,
Sauck
E
,
Raffini
LJ
.
A survey of pediatric hematology/oncology specialists regarding management of central line associated venous thrombosis
.
Pediatr Blood Cancer.
2016
;
64
(
7
):
e26383
.
10.
Mitchell
LG
,
Goldenberg
NA
,
Male
C
,
Kenet
G
,
Monagle
P
,
Nowak-Göttl
U
;
Perinatal and Paediatric Haemostasis Subcommittee of the SSC of the ISTH
.
Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children
.
J Thromb Haemost.
2011
;
9
(
9
):
1856
-
1858
.
11.
Schroeder
AR
,
Axelrod
DM
,
Silverman
NH
,
Rubesova
E
,
Merkel
E
,
Roth
SJ
.
A continuous heparin infusion does not prevent catheter-related thrombosis in infants after cardiac surgery
.
Pediatr Crit Care Med.
2010
;
11
(
4
):
489
-
495
.
12.
Massicotte
P
,
Julian
JA
,
Gent
M
, et al;
PROTEKT Study Group
.
An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial
.
Thromb Res.
2003
;
109
(
2-3
):
101
-
108
.
13.
Ruud
E
,
Holmstrøm
H
,
De Lange
C
,
Hogstad
EM
,
Wesenberg
F
.
Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study
.
Acta Paediatr.
2006
;
95
(
9
):
1053
-
1059
.
14.
Faustino
EVS
,
Shabanova
V
,
Raffini
LJ
, et al;
CRETE Trial Investigators and the Pediatric Critical Care Blood Research Network (BloodNet) of the Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI)
.
Efficacy of early prophylaxis against catheter-associated thrombosis in critically Ill children: a Bayesian phase 2b randomized clinical trial
.
Crit Care Med.
2020
;
49
(
3
):
e235
-
e246
.
15.
Faustino
EVS
,
Raffini
LJ
,
Hanson
SJ
, et al
.
Age-dependent heterogeneity in the efficacy of prophylaxis with enoxaparin against catheter-associated thrombosis in critically Ill children: a post hoc analysis of a Bayesian phase 2b randomized clinical trial
.
Crit Care Med
.
2021
;
49
(
4
):
e369
e380
.
16.
Jaffray
J
,
Witmer
C
,
O’Brien
SH
, et al
.
Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children
.
Blood.
2020
;
135
(
3
):
220
-
226
.
17.
Nowak-Göttl
U
,
van Ommen
H
,
Kenet
G
.
Thrombophilia testing in children: what and when should be tested?
Thromb Res.
2018
;
164
:
75
-
78
.
18.
Gavva
C
,
Sarode
R
,
Zia
A
.
A clinical audit of thrombophilia testing in pediatric patients with acute thromboembolic events: impact on management
.
Blood Adv.
2017
;
1
(
25
):
2386
-
2391
.
19.
Mahajerin
A
,
Webber
EC
,
Morris
J
,
Taylor
K
,
Saysana
M
.
Development and implementation results of a venous thromboembolism prophylaxis guideline in a tertiary care pediatric hospital
.
Hosp Pediatr.
2015
;
5
(
12
):
630
-
636
.
20.
Children’s Hospitals’ Solutions for Patient Safety
. SPS prevention bundles. https://www.solutionsforpatientsafety.org/wp-content/uploads/SPS-Prevention-Bundles-1.pdf. Accessed April 20, 2021.
21.
Yen
J
,
Van Arendonk
KJ
,
Streiff
MB
, et al
.
Risk factors for venous thromboembolism in pediatric trauma patients and validation of a novel scoring system: the risk of clots in kids with trauma score
.
Pediatr Crit Care Med.
2016
;
17
(
5
):
391
-
399
.
22.
Connelly
CR
,
Laird
A
,
Barton
JS
, et al
.
A clinical tool for the prediction of venous thromboembolism in pediatric trauma patients
.
JAMA Surg.
2016
;
151
(
1
):
50
-
57
.
You do not currently have access to this content.

Sign in via your Institution

Sign In